Equities

Cleanspace Holdings Ltd

CSX:ASX

Cleanspace Holdings Ltd

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.37
  • Today's Change0.015 / 4.23%
  • Shares traded77.29k
  • 1 Year change+25.42%
  • Beta0.7626
Data delayed at least 20 minutes, as of Nov 15 2024 04:47 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in AUDIncome statement in AUDView more

Year on year Cleanspace Holdings Ltd grew revenues 30.01% from 12.09m to 15.72m while net income improved from a loss of 8.13m to a smaller loss of 3.13m.
Gross margin72.25%
Net profit margin-19.89%
Operating margin-30.62%
Return on assets-11.37%
Return on equity-15.23%
Return on investment-13.04%
More ▼

Cash flow in AUDView more

In 2024, cash reserves at Cleanspace Holdings Ltd fell by 368.10k. However, Cash Flow from Investing totalled 2.00m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.73m for operations while cash used for financing totalled 637.10k.
Cash flow per share-0.0283
Price/Cash flow per share--
Book value per share0.2469
Tangible book value per share0.2469
More ▼

Balance sheet in AUDView more

Cleanspace Holdings Ltd has a Debt to Total Capital ratio of 15.28%, unchanged from the previous year.
Current ratio4.69
Quick ratio3.92
Total debt/total equity0.1804
Total debt/total capital0.1528
More ▼

Growth rates in AUD

Year on year, growth in earnings per share excluding extraordinary items increased 61.65%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
61.65
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.